港股異動 | 彩客化學(1986.HK)高開3.4% 2019年純利大增132.6%至5.183億元
格隆匯3月26日丨彩客化學(1986.HK)高開3.4%,報1.52港元,暫成交1.8萬港元,最新總市值15.8億港元。彩客化學昨晚發佈2019年業績稱,期內實現收益18.183億元(人民幣,下同),同比增長20%;毛利10.41億元,同比增長98.6%;純利5.183億元,同比增長132.6%;每股基本盈利0.50元;擬派末期股息每股0.092元,連同特別股息每股0.058元,2019年度的股息總額將為每股人民幣0.150元。公告表示,收益上升主要由於染料中間體產品售價上漲同時銷量下降所抵銷導致。毛利方面,由於染料中間體產品價格上漲幅度較大,故集團毛利較2018年上升約98.6%,集團整體毛利率較2018年由約34.6%上升至2019年約57.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.